Stopped prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly diagnosed GMB pts as RT plus concomitant and adjuvant TMZ
Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG: poly ICLC
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins